Predictive value of 3'-deoxy-3'-18F-fluorothymidine PET in the early response to anti-programmed death-1 therapy in patients with advanced non-small cell lung cancer.
Masayuki SatoYukihiro UmedaTetsuya TsujikawaTetsuya MoriMiwa MorikawaMasaki AnzaiYuko WasedaMaiko KadowakiYasushi KiyonoHidehiko OkazawaTamotsu IshizukaPublished in: Journal for immunotherapy of cancer (2022)
jRCTs051180147.